Johan Linderoth
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Viral-associated cancers and disorders
- Cancer survivorship and care
Papers in
-
- Lymphoma Diagnosis and Treatment 26
- Oncology 2
- Cancer survivorship and care 1
- Viral-associated cancers and disorders 1
- Co-authors
- Mats Jerkeman (13 shared papers)Eva K. Cavallin-Ståhl (8 shared papers)Gunilla Enblad (12 shared papers)Mattias Berglund (7 shared papers)Martin Erlanson (5 shared papers)Michael R. Dictor (3 shared papers)Mats Ehinger (7 shared papers)Stein Kvaløy (2 shared papers)
In The Last Decade
Johan Linderoth
27 papers receiving 624 citations
Peers
Comparison fields: 5 of 44
- Pathology and Forensic Medicine 418
- Oncology 74
- Cancer Research 25
- Cell Biology 19
- Genetics 11
Countries citing papers authored by Johan Linderoth
This map shows the geographic impact of Johan Linderoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Linderoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Linderoth more than expected).
Fields of papers citing papers by Johan Linderoth
This network shows the impact of papers produced by Johan Linderoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Linderoth. The network helps show where Johan Linderoth may publish in the future.
Co-authors
The 25 scholars most cited alongside Johan Linderoth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 165 | |
| 2 | Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. | 2003 | 77 |
| 3 | 2007 | 48 | |
| 4 | 2008 | 37 | |
| 5 | 2015 | 33 | |
| 6 | 2008 | 32 | |
| 7 | 2009 | 27 | |
| 8 | 2016 | 24 | |
| 9 | 2007 | 23 | |
| 10 | 2019 | 18 | |
| 11 | 2017 | 16 | |
| 12 | 2022 | 16 | |
| 13 | 2008 | 14 | |
| 14 | 1999 | 13 | |
| 15 | 2011 | 13 | |
| 16 | 2007 | 12 | |
| 17 | 2010 | 12 | |
| 18 | 2016 | 12 | |
| 19 | 2012 | 11 | |
| 20 | 2009 | 9 |
About Johan Linderoth
Johan Linderoth is a scholar working on Pathology and Forensic Medicine, Oncology, Cancer Research, Economics and Econometrics and Epidemiology, having authored 28 papers that have together received 635 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (26 papers), Cancer survivorship and care (1 paper), Viral-associated cancers and disorders (1 paper), Cancer, Lipids, and Metabolism (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Economic and Financial Impacts of Cancer (1 paper) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (418 citations), Oncology (74 citations), Cancer Research (25 citations), Cell Biology (19 citations) and Genetics (11 citations). Johan Linderoth has collaborated with scholars based in Sweden, Norway and Denmark. Frequent co-authors include Mats Jerkeman, Eva K. Cavallin-Ståhl, Gunilla Enblad, Mattias Berglund, Martin Erlanson, Michael R. Dictor, Mats Ehinger, Stein Kvaløy, Emina Torlakovic and Göran Roos. Their work appears in journals such as British Journal of Haematology, HemaSphere, The Journal of Pathology, Blood and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.